An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
A legfontosabb adatok
- Ki végzi
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Hol
- Bethesda (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 2000 fő, tervezett
- Kezdés
- 1997. ápr. 21.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- Tissue specimen collection
- MRI
- A regiszteradat frissítve
- 2026. október 19.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
A vizsgálat 2 és 70 év közötti, agyalapi mirigy vagy a közeli hipotalamusz daganatával vagy ehhez kapcsolódó betegséggel élő embereket keres. Az ilyen betegek családtagjai is részt vehetnek.
- Életkor
- 2–70 év a daganatos betegeknél. A családtagok bármilyen korúak lehetnek.
- Nem
- Nemtől függetlenül bárki részt vehet.
- A betegség stádiuma
- Az agyalapi mirigy és a hipotalamusz területének daganata vagy ehhez kapcsolódó betegség, amelyet korábbi képalkotó vizsgálat vagy hormonvizsgálat igazol.
A részvétel fő kizáró okai
- Terhesség
- Bármilyen orvosi, testi, pszichiátriai vagy szociális állapot, amely miatt a vizsgálók szerint a részvétel nem a személy érdeke
- Súlyosan beteg, instabil állapot vagy súlyos szervelégtelenség, amely korlátozza a hormonvizsgálatokat
A regiszter feltételei, szó szerint
Mind a 8 feltétel megnézéseKevesebb
Ki nem vehet részt
- Patients with any medical, physical, psychiatric, or social condition, which, in the opinion of the investigators, would make participation in this protocol not in their best interest, will be excluded from the study
- Patients who are critically ill, unstable, or with severe organ failure that may affect/limit the endocrine evaluation and place unsustainable demands on CC or NICHD resources may be excluded
- Pregnancy: Pregnancy will be evaluated only in participants of reproductive age (from 10 years old until 60 years of age unless menopause has already occurred per clinical report of the participant); For participants enrolled as external participants or under the Linkage study (where research activities include no more than blood draws), any female who could possibly become pregnant will be screened using clinical criteria (history, with pregnancy testing only if indicated) for exclusion and this information will be documented in the consent process note in EMR. If a participant has initially been registered as external location and then presents on-site, then pregnancy test will be performed if within the reproductive age group
- An individual who meets any of the following criteria will be excluded from participation in this study:
Egyéb feltételek
- INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female with:; Evidence for the existence of a tumor of the hypothalamic-pituitary unit or related disorder, as indicated by previously obtained imaging studies or biochemical investigation of the hypothalamo-hypophyseal function (aged 2 years to 70 years); or; Family members (any age) of patients with a family history of tumors of the hypothalamic-pituitary unit or related disorders as part of the linkage part of the study, or; Members (any age) of a kindred suspected of having an inherited form of neoplasia of the hypothalamic-pituitary unit or related disorder, as evidenced by results of a patient enrolled in this protocol, as part of the linkage part of the study
- Ability of the subject or LAR to understand and the willingness to sign a written informed consent document
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 2 és 70 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- National Institutes of Health Clinical CenterBethesda, Egyesült ÁllamokContact: Ka Wing J LamRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors (eg craniopharyngioma) are included among the most common central nervous system tumors in childhood. The gene(s) involved in the pathogenesis of these tumors are largely not known; their possible association with other developmental defects or inheritance pattern(s) has not been investigated. The present study serves as a (i) screening/training, and, (ii) a research protocol.
A teljes eredeti leírásKevesebb
As a screening and training study, this protocol allows our Institute to admit children with tumors of the hypothalamic-pituitary unit to the pediatric endocrine clinics and wards of the NIH Clinical Center for the purposes of
(i) training our fellows and students in the identification of genetic defects associated with pituitary tumor formation, and
(ii) teaching our fellows and students the recognition, management and complications of pituitary tumors
As a research study, this protocol aims at
(i) developing new clinical studies for the recognition and therapy of pituitary tumors; as an example, two new studies have emerged within the context of this protocol: (a) investigation of a new research magnetic resonance imaging (MRI) tool and its usefulness in the identification of pituitary tumors, and (b) investigation of the psychological effects of cortisol secretion in pediatric patients with Cushing disease. Continuation of this protocol will eventually lead to new, separate protocols that will address all aspects of diagnosis of pituitary tumors and their therapy in childhood.
(ii) Identifying the genetic components of pituitary oncogenesis; those will be investigated by (a) studying the inheritance pattern of pituitary tumors in childhood and their possible association with other conditions in the families of the patients, and (ii) collecting tumor tissues and examining their molecular genetics. As with the clinical studies, the present protocol may help generate ideas for future studies on the treatment and clinical follow up of pediatric patients with tumors of the pituitary gland and, thus, lead to the development of better therapeutic regimens for these neoplasms.
A vizsgálat csoportja
- Patients with pituitary tumors or hypothalmic defects
Kezelés: Tissue specimen collection és MRI
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Clinical and Genetic Investigation of Pituitary and Hypothalamic Tumors and Related Disorders
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 12.
- Kérdések a feltételekről
- Forrás: NCT00001595: ki vehet részt
- Publikációk
- Body Composition and Fat Deposition in Children with Cushing Disease and Associations with Cardiometabolic Risk Factors.The Journal of pediatrics, 2026
- Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing's disease.Pituitary, 2025
- Genetic drivers of Cushing's disease: Frequency and associated phenotypes.Genetics in medicine : official journal of the American College of Medical Genetics, 2022
- Rare Germline DICER1 Variants in Pediatric Patients With Cushing's Disease: What Is Their Role?Frontiers in endocrinology, 2020
- Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.The Journal of clinical endocrinology and metabolism, 2020
- Mini-review of hair cortisol concentration for evaluation of Cushing syndrome.Expert review of endocrinology & metabolism, 2018
- Postoperative Diabetes Insipidus and Hyponatremia in Children after Transsphenoidal Surgery for Adrenocorticotropin Hormone and Growth Hormone Secreting Adenomas.The Journal of pediatrics, 2018
- Coagulation Profile Dynamics in Pediatric Patients with Cushing Syndrome: A Prospective, Observational Comparative Study.The Journal of pediatrics, 2016
- Anthropometric measures and fasting insulin levels in children before and after cure of Cushing syndrome.Clinical nutrition (Edinburgh, Scotland), 2012
- A regiszteradat frissítve
- 2026. október 19.